Author

Peter Ferenci 1

1 Medizin. Universität Wien - Innere Medizin III, Medizin. Universität Wien; Wien/AT

Central Europe

Peter Ferenci

EFFECT OF FIBRATE-ADD-ON TREATMENT IN PRIMARY BILIARY CHOLANGITIS PATIENTS WITH AN INSUFFICIENT RESPONSE TO URSODEOXYCHOLIC ACID (UDCA)

Clarissa Weber-Freissmuth, Karin Kozbial, Albert Friedrich Staettermayer, Sandra Beinhardt, Rafael Stern, Peter Ferenci, Michael Trauner, Harald Hofer

Elevated ferritin

Peter Ferenci

Genetic liver disease in adults

Peter Ferenci

Hepatic encephalopathy

Peter Ferenci

Hepatitis C

Peter Ferenci

HEPATOCELLULAR CARCINOMA INCIDENCE IN CHRONIC HEPATITIS C PATIENTS ACCORDING TO SUSTAINED VIROLOGIC RESPONSE (SVR) AND FLUCTUATION OF ALFA FETO-PROTEIN LEVELS DURING ANTIVIRAL TREATMENT

Tuul Purevsambuu, Simona Bota, Florian Hucke, Harald Hofer, Peter Ferenci, Wolfgang Sieghart, Markus Peck-Radosavljevic

MANAGEMENT OF HAEMOGLOBIN DECREASE IN PATIENTS TREATED WITH ABT-450/RITONAVIR/OMBITASVIR AND DASABUVIR WITH OR WITHOUT RIBAVIRIN IN HCV GENOTYPE 1-INFECTED PATIENTS

Daniel Forton, Hendrik Reesink, David E. Bernstein, Thomas Sepe, John Vierling, William King, Yiran Hu, Jeffrey Enejosa, Daniel E. Cohen, Yan Luo, Marcos Pedrosa, Peter Ferenci

Nucleos(t)ide analogues-containing therapies of HCV

Peter Ferenci

Optimal treatment for hepatic encephalopathy: Are we there yet?

Peter Ferenci

Item 1 - 10 / 29
1
2 3